Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines

详细信息    查看全文

• 作者：Matthew Bennett ; MD (Co-Chair)^a (Primary Panel) ; Ratika Parkash ; MD^b (Primary Panel) ; Pablo Nery ; MD^c (Primary Panel) ; Mario Sé ; né ; chal ; MD^d (Primary Panel) ; Blandine Mondesert ; MD^e (Primary Panel) ; David Birnie ; MD^c (Primary Panel) ; Laurence D. Sterns ; MD^f (Primary Panel) ; Claus Rinne ; MD^g (Primary Panel) ; Derek Exner ; MD^h (Primary Panel) ; Franç ; ois Philippon ; MD (Co-Chair)^d ; ^{francois.philippon@fmed.ulaval.ca} (Primary Panel) ; Debra Campbell ; RNⁱ (Secondary Panel) ; Jafna Cox ; MD^b (Secondary Panel) ; Paul Dorian ; MD^j (Secondary Panel) ; Vidal Essebag ; MD^k (Secondary Panel) ; Andrew Krahn ; MD^a (Secondary Panel) ; Jaimie Manlucu ; MD^l (Secondary Panel) ; Franck Molin ; MD^d (Secondary Panel) ; Michael Slawnych ; MD^h (Secondary Panel) ; Mario Talajic ; MD^e (Secondary Panel)
• 刊名：Canadian Journal of Cardiology
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：33
• 期：2
• 页码：174-188
• 全文大小：1141 K
• 卷排序：33

文摘

Sudden cardiac death is a major public health issue in Canada. However, despite the overwhelming evidence to support the use of implantable cardioverter defibrillators (ICDs) in the prevention of cardiac death there remains significant variability in implantation rates across Canada. Since the most recent Canadian Cardiovascular Society position statement on ICD use in Canada in 2005, there has been a plethora of new scientific information to assist physicians in their discussions with patients considered for ICD implantation to prevent sudden cardiac death due to ventricular arrhythmias. We have reviewed, critically appraised, and synthesized the pertinent evidence to develop recommendations regarding: (1) ICD implantation in the primary and secondary prevention of sudden cardiac death in patients with and without ischemic heart disease; (2) when it is reasonable to withhold ICD implantation on the basis of comorbidities; (3) ICD implantation in patients listed for heart transplantation; (4) implantation of a single- vs dual-chamber ICD; (5) implantation of single- vs dual-coil ICD leads; (6) the role of subcutaneous ICDs; and (7) ICD implantation infection prevention strategies. We expect that this document, in combination with the companion article that addresses the implementation of these guidelines, will assist all medical professionals with the care of patients who have had or at risk of sudden cardiac death.